Q4 2028
Ends Dec 30, 2028
Revenue
$1.1B
$1.1B to $1.2B
EPS
0.96
0.93 to 1.01
No analyst count
EPS: No analyst count
May 4, 11:25 PM UTC
stable/analyst-estimates
Healthcare
Live Price
Offline$449.45
+4.54% today
Window Change
+64.63%
Window
Sep 4, 2025 → Jun 23, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 200 bars · Sep 4, 2025 → Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) is a Healthcare stock with a market cap of $5.79B. The stock last traded around $449.45 and up 64.6% across the available one-year price window (Sep 4, 2025 → Jun 23, 2026). Baseline metrics include revenue growth of +2.1%, EPS growth of -119.7%, a dividend yield of 0.5%. What stands out right now is revenue +2.1%, EPS -119.7%, free cash flow -68.2% with operating margin 5.4% and ROIC -1.5%. The dividend is present but secondary, with a yield around 0.5%. Valuation is more restrained than many high-expectation growth names at price/sales 1.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines BRKRP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
BRKRP
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
BRKRP Max Drawdown
-34.95%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BRKRP and SPY.
EPS Consensus
0.96
Range 0.93 -> 1.01
No analyst count
vs prior: +29.7%Revenue Outlook
$1.1B
Range $1.1B -> $1.2B
No analyst count
vs prior: +15.3%Price Target
--
-- -> --
No analyst count
Recommendations
--
No recommendation feed
No date
Consensus Spread
Lower spread suggests tighter agreement across covering analysts.
Next Earnings
EPS --
Revenue --
No analyst count
EPS Revisions
No recent EPS revision rows
0 revision rows
Trend
Consensus average across visible periods
Trend
Average analyst revenue estimate
Timeline
Sorted by period end date. Includes both cached rows and live fallbacks from the configured analyst feed.
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.